As;Suizidversuch mit mirtazapin

Nervenheilkunde

Volumn 16, Issue 6, 1997, Pages 353-355

  Holzbach, R ^a   Mahne Ch ^a   Jahn, H ^a   Pajonk, F G ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Attempted suicide; Edema; Lost of efficacy; Mirtazapine; Overdose

Indexed keywords

EID: 7844221637     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Bremner JD. A double-blind comparision on Org 3770, amitriptylin and placebo in major depression. J Clin Psychiatry 1995; 56:519-25.
2. Claghorn JL, Lesern MD. A double-blind placebo controlled study of Org 3770 in depressed outpatients. J Affective Disord 1995; 34:165-71.
3. Fritze J. Unerwünschte Begleitwirkungen der Antidepressiva und ihre Behandlung. In: Therapie psychiatrischer Erkrankungen. Möller HJ (Hrsg). Stuttgart: Enke 1993: 287-301.
4. Hoess MJAJM, Zeijpveld JHB. First report of mirtazapine overdose. Inf Clin Psychopharmacology 1996; II: 147.
5. Smith WT, Glaudin V, Panagides J, Gilvary E. Mirtazapine vs amitriptyline vs placebo in the treatment of major depressive disorder. Psychopharmacol Bull 1990; 26:191-6.
6. Van Moffaert M, De Wilde J, Vereecken A et al. Mirtazapine is more effective than trazo-done. A controlled study in hospitalised patients with major depression. Int Clin Psychopharmacol 1995; 10:3-9.
7. Voortman G, Paanakker JE. Unavailability of Mirtazapine from Remeron® Tablets after Single and Multiple Oral Dosing. Hum Psychopharmacol 1995; 10:83-96.
8. Zivkov M, De Jong GD. Org 3770 vs amitriptyline: a 6-week, randomised double-blind multicentre trial in hospitalised depressed patients. Hum Psychopharmacol 1995; 10: 173-80.
9. Kasper S, Schindler S, Neumeister A. Risk of suicide in depression and its implication for psychopharmacological treatment. Int Clin Psychopharmacology 1996; II: 71.